September 27, 2017
Home / Medical News / Surgical treatment, RT Equivalent for Keep watch over of Mind Metastases (CME/CE)
(MedPage As of late) — Early SRS receive advantages disappeared through the years
September 26, 2017
- A new strategy proposed for drug discovery
- Lactation May Lower T2D Risk in Younger Women
- New Atopic Dermatitis Yardstick provides practical guidance and management insights
- New biodegradable pressure sensor could help monitor serious health conditions
- HSS orders Sectra’s 3D pre-operative planning solution for improving patient outcomes
- Study identifies six new genes regions associated with diabetes
- Women do not receive timely diagnosis for heart disease
- AbbVie’s Upadacitinib Shows Positive Results as Monotherapy in Phase 3 Rheumatoid Arthritis Study, Meeting All Primary and Key Secondary Endpoints
- Should President Trump’s Physical Include a Cognitive Screen?
- Could gene therapy someday eliminate HIV?
- Researchers identify new anti-inflammatory drug target
- Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers
- Trunk Imaging Tied to Higher Nephrectomy Risk
- Campaigners incensed at failings in Africa AIDS war
- Research opens door to development of new treatment for type 2 diabetes
- Bariatric surgery extends lifespan in obese patients, shows study
- Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients with Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease
- Ewww Moments in the ER: That’s Improbable!
- Methods from optogenetics, machine learning should help improve treatment options for stroke patients
- Booze may help or harm the heart, but income matters